Vitamin D: A potential role in reducing suicide risk?

International Journal of Adolescent Medicine and Health

Volumn 23, Issue 3, 2011, Pages 157-165

  Tariq, Muhammad M ^a,b   Streeten, Elizabeth A ^a   Smith, Helen A ^a   Sleemi, Aamar ^a   Khabazghazvini, Baharak ^a   Vaswani, Dipika ^a   Postolache, Teodor T ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b St Elizabeths Hospital   (United States)

Author keywords

mental health; suicide; suicide risk factors; vitamin D

Indexed keywords

7 DEHYDROCHOLESTEROL; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; INTERLEUKIN 1; INTERLEUKIN 12; PLACEBO; RETINOL; VITAMIN D;

ANXIETY DISORDER; AUTOIMMUNE DISEASE; BONE MINERALIZATION; CALCIUM ABSORPTION; CATABOLISM; DISEASE ASSOCIATION; DISEASE SEVERITY; EXCRETION; FAMILY HISTORY; FIBROMYALGIA; GENETIC VARIABILITY; HEREDITY; HUMAN; MOOD DISORDER; NEOPLASM; NUTRITIONAL STATUS; OSTEOMALACIA; PHOTOTHERAPY; REVIEW; RICKETS; RISK FACTOR; RISK REDUCTION; SCHIZOPHRENIA; SEASONAL AFFECTIVE DISORDER; SUICIDE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; HUMANS; MENTAL DISORDERS; MENTAL HEALTH; NEOPLASMS; RISK FACTORS; SEASONS; SKIN; SUICIDE; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80052709257     PISSN: 03340139     EISSN: 21910278     Source Type: Journal    
DOI: 10.1515/IJAMH.2011.038     Document Type: Review

References (67)

1. Schmidtke A, Bille-Brahe U, Deleo D, Kerkhof A, Bjerke T, et al. Attempted suicide in Europe: Rates, trends and sociodemographic characteristics of suicide attempts during the period 1989-1992. Results of WHO/EURO multicenter study on parasuicide. Acta Psychiatr Scand 1996;93:327-38.
2. Wunderlich U, Bronisch T, Wittchen HU. Comorbidity patterns in adolescents and young adults with suicide attempts. Eur Arch Psychiatry Clin Neurosci 1997;248:87-95.
3. National Institute of Mental Health (NIHM). The numbers count: Mental disorders in America. Available at http://www.nimh.nih. gov/health/publications/ the-numbers-count-. Accessed June 12, 2009.
4. Gray RW, Omdahl JL, Ghazarian JG, Horst RL. Induction of 25-OH-vitamin D 3 24- and 23-hydroxylase activities in partially purified renal extracts from pigs given exogenous 1,25-(OH)2D 3 Steroids 1990;55:395-8.
5. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266-81.
6. Holock MF. Vitamin D: Molecular biology, physiology, and clinical applications. Totowa, NJ: Humana Press, 1999.
7. Feldman D, Pike JW, Glorieux FH, editors. Vitamin D, 2nd ed. London: Elsevier, Academic Press, 2005.
8. Panda DK, Miao D, Bolivar I, Li J, Huo R, et al. Inactivation of 25-hydroxyvitamin D 1a-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004;279:16754-66.
9. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, et al. Vitamin D status predicts physical performance and its decline in older persons. Deficiency and neuromuscular performance in the Longitudinal Aging Study Amsterdam (LASA). J Clin Endocrinol Metab 2007;92:2058-65.
10. Holick MF. Vitamin D status: Measurements, interpretation, and clinical implication. Ann Epidemiol 2009;19:73-8.
11. Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR, et al. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 2009;122:1056-60.
12. Romangoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, et al. Short- and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (Vitamin D2) or cholecalciferol (Vitamin D3) in the elderly. J Clin Endocrinol Metab 2008;93:3015-20.
13. Barake R, Weiler H, Payette H, Gray-Donald K. Vitamin D supplement consumption is required to achieve a minimal target 25-hydroxyvitamin D concentration of > or = 75 nmol/L in older people. J Nutr 2010;140:551-6.
14. Holick MF, MacLaughlin JA, Doppelt SH. Regulation of cutaneous previtamin D3 photosynthesis in man: Skin pigment is not an essential regulator. Science 1981;211:590-3.
15. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D 3 Lancet 1982;1:74-6.
16. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996;93:7861-4.
17. Mathieu C, Gysemans C, Guilietti A, Bouillon R. Vitamin D and diabetes. Diabetologica 2005;48:1247-57.
18. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5.
19. Nagpal S, Na S, Rathanchalan R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-87.
20. Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF. Genetic and non-genetic correlates of vitamin K and D. Eur J Clin Nutr 2009;63:458-64.
21. Wang TJ, Zhang F, Richards JB, Kestenbaum B, vanMeurs JB, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010;376:180-8.
22. Grant WB, Mohr SB. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 2009;19:446-54.
23. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61.
24. Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, et al. Vitamin D and prevention of breast cancer: Pooled analysis. J Steroid Biochem Mol Biol 2007;103:708-11.
25. Lui Z, Caldeeron JI, Zhang Z, Sturgis EM, Spitz MR, et al. Polymorphisms of vitamin D receptor gene protect again the risk of head and neck cancer. Pharmacogenet Genomics 2005; 15:159-65.
26. Deluca H, Cantorna M. Vitamin D: Its role and uses in immunology. FASEB J 2001;15:2579-85.
27. Royal W III, Mia Y, Li H, Naunton K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 2009;213:135-41.
28. Mazza M, Mazza O, Pomponi M, DiNicola M, Padua L, et al. What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? Compr Psychiatry 2009;30:240-4.
29. Maletic V, Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Frontiers Biosci 2009;14:5291-338.
30. Assumpcao A, Cavalcante AB, Capela CE, Sauner JF, Chalot SD, et al. Prevalence of fibromyalgia in low socioeconomic status population. BMC Musculoskelet Disord 2009;10:1-20.
31. Lansdowne ATG, Provost ST. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998;135:819-23.
32. Lipska B, Weinberger D. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 2000;23:223-39.
33. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: A review of the literature. Schizophr Res 1997;28:1-38.
34. Saha S, Chant DC, Welham JL, McGrath JJ. The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatr Scand 2006;114:36-9.
35. Hoogendijk WJG, Lips P, Dik MG, Deeg DJ, Beekman ATF, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-12.
36. Sachan A, Gupta R, Das V, Agarwal A, Awasthi PK, et al. High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. Am J Clin Nutr 2005; 81:1060-4.
37. McGrath J, Eyles D, Mowry B, Yolken R, Buka S. Low maternal vitamin D as a risk factor for schizophrenia: A pilot study using banked sera. Schizophr Res 2003;63:73-8.
38. Geerlings SW, Beekman AT, Deeg DJ, Twisk JW, Van Tilburg W. Duration and severity of depression predict mortality in older adults in the community. Psychol Med 2002;32:609-18.
39. Hawton K, van Heeringen K. Suicide. Lancet 2009;373: 1372-81.
40. Barnard K, Colon- Emeric C. Extraskeletal effects of vitamin D in older adults: Cardiovascular disease, mortality, mood and cognition. AM J Geriat Pharmacother 2010;8:4-33.
41. Arnold LM. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 2006;8:212.
42. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: Global perspective. Ann Epidemiol 2009;19: 468-83.
43. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998;173:11-53.
44. Schneider B, Weber B, Frensch A, Stein J, Fritze J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 2000;107:839-42.
45. Cavanagh JTO, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: A systematic review. Psychol Med 2003;33:395-405.
46. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterlook K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: Randomized double blind trial. J Intern Med 2008;264:599-609.
47. Chattopadhyay N, Evliyaoglu C, Heese O, Carroll R, Sanders J, et al. Regulation of secretion of PTHrP by Ca(2 + )-sensing receptor in human astrocytes, astrocytomas, and meningiomas. Am J Physiol Cell Physiol 2000;279:C691-9.
48. 3 enhances mood in healthy subjects during winter. Psychpharmacology (Berlin) 1998;135:319-23.
49. Basile LA, Taylor SN, Wagner CL, Quinones L, Hollis BW. Neonatal vitamin D status at birth at latitude 32°72' : Evidence of deficiency. J Perinatol 2007;27:568-71.
50. Gloth FM III, Alam W, Hollis B. Vitamin D vs. broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999;3:5-7.
51. 3 levels in seasonal affective disorder: Effects of light. Psychopharmacology (Berlin) 1994;116:515-6.
52. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: A reexamination. Arch Gen Psychiatry 2005;62:247-53.
53. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: Systematic review of risk factors. Br J Psychiatry 2005;187:9-20.
54. Harrison G. Searching for the causes of schizophrenia: The role of migrant studies. Schizophr Bull 1990;16:663-71.
55. Selten JP, Veen N, Feller W, Blom JD, Schols D, et al. Incidence of psychotic disorders in immigrant groups to the Netherlands. Br J Psychiatry 2001;178:367-72.
56. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, et al. Familial and non-familial risk factors for schizophrenia: A population-based study. Schizophr Res 1998;29:13.
57. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995;61:638S-45S.
58. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002;76:187-92.
59. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, " Just the Facts " : What we know in 2008 part 1: Overview. Schizophr Res 2008;100:4-19.
60. Parikh V, Evans DR, Khan MM, Mahadik SP. Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: Possible implications for treatment outcome. Schizophr Res 2003;60:117-23.
61. Feron F, Burne TH, Brown J, Smith E, McGrath JJ, et al. Developmental vitamin D 3 deficiency alters the adult rat brain. Brain Res Bull 2005;65:141-8.
62. Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 2007;103:538-45.
63. Almeras L, Eyles D, Benech P, Laffite D, Villard C, et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics 2007;7:769-80.
64. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000;28:53-67.
65. Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans K, et al. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 2008;88:1535-42.
66. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, et al. A phase I/II dose-escalation trial of vitamin D 3 and calcium in multiple sclerosis. Neurology 2010;74:1852-9.
67. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18.